A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs
A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs
Novavax Unveils Plan to Cut Costs by Another $300 Million
Novavax Unveils Plan to Cut Costs by Another $300 Million
Apple, McDonald’s, Airbnb Earnings Set to Strip Away GDP Gloss
Apple, McDonald’s, Airbnb Earnings Set to Strip Away GDP Gloss
Nobel Prize for mRNA vaccines: 5 things to know
Nobel Prize for mRNA vaccines: 5 things to know
Nobel Prize in medicine goes to Katalin Karikó and Drew Weissman for work on mRNA Covid-19 vaccines
Nobel Prize in medicine goes to Katalin Karikó and Drew Weissman for work on mRNA Covid-19 vaccines
Pfizer’s Maternal Vaccine for RSV Wins Backing from CDC Panel
Pfizer’s Maternal Vaccine for RSV Wins Backing from CDC Panel
Stocks Set for Mixed Open as CPI Signals Fed Pause: Markets Wrap
Stocks Set for Mixed Open as CPI Signals Fed Pause: Markets Wrap
Moderna Raises Covid Shot Sales Guidance on Japan, US Pacts
Moderna Raises Covid Shot Sales Guidance on Japan, US Pacts
AI Drug Discovery Firm Recursion Surges Following $50 Million Nvidia Investment
AI Drug Discovery Firm Recursion Surges Following $50 Million Nvidia Investment
Moderna inks deal to make mRNA medicines in China
Moderna inks deal to make mRNA medicines in China
Moderna Signs Deal to Make mRNA Vaccines for Chinese Market
Moderna Signs Deal to Make mRNA Vaccines for Chinese Market
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
«12»